KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationInvestment in Debt & EquityLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Inovio Pharmaceuticals (INO) Long-Term Debt Issuances (2019 - 2020)

Inovio Pharmaceuticals (INO) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $171620.0 as the latest value for Q2 2020.

  • Quarterly Long-Term Debt Issuances rose 100.23% to $171620.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $171620.0 through Sep 2021, down 95.9% year-over-year, with the annual reading at $171620.0 for FY2020, 99.82% down from the prior year.
  • Long-Term Debt Issuances hit $171620.0 in Q2 2020 for Inovio Pharmaceuticals, down from $4.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $93.4 million in Q3 2019 to a low of -$75.7 million in Q2 2019.